EAM Investors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
NAMA
EAM Investors's CDNA Position: Q4 2024 in Review
EAM Investors sold out of CareDx (CDNA) in Q4 2024, closing a stake of 107,890 shares — an estimated $3.37M sold.
EAM Investors first reported a position in CDNA in Q4 2017 and held it in 9 quarters. The position peaked at $3.61M in Q4 2018. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.
- EAM Investors reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
- EAM Investors sold 107,890 CareDx shares in Q4 2024, an estimated $3.37M.
- EAM Investors first reported a position in CareDx in Q4 2017 and held it in 9 quarters.
- EAM Investors's CareDx position peaked at $3.61M in Q4 2018.
- 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.
Based on EAM Investors's 13F filing for Q4 2024, filed 13 Feb 2025.